Home › Articles › Volume 8, Issue 2 › Efficacy of Mifepristone versus GNRH Analogue in the...
Moradabad, India
Original Article
Pharmacology

Efficacy of Mifepristone versus GNRH Analogue in the Treatment of Uterine Leiomyoma- A Comparative Study


Volume 8, Issue 2, Pages 01-04

Authors

Georgy Joy Eralil1, Junaid Naina M2, T. N. Kumar3
Affiliation:
1Professor, Department of Obstetrics & Gynaecology, Sree Narayana Institute of Medical Science, Chalakka, Emakulam,
2Post Graduate Student, Department of Pharmacology, Sree Narayana Institute of Medical Science, Chalakka, Emakulam,
3Professor & HOD, Department of Pharmacology, Sree Narayana Institute of Medical Science, Chalakka, Emakulam,

Corresponding Author

Junaid Naina M

Abstract

Background: Uterine fibroids also called as uterine leiomyoma is the most common benign tumor of the uterus. Most women develop one or more uterine leiomyoma during their reproductive years. Hence; we assessed the efficacy of Mifepristone 25mg versus Inj.Leuprolide acetate 3.75mg in reducing size of uterine myoma. Subjects and Methods: The study was planned for detecting difference of 15 percent in the outcome variables between the two groups and Standard deviation of 156.00, with 90% statistical power and 5% level of significance, the sample size was calculated to be 70 for the study. The study subjects were randomly assigned into 2 groups of 35 patients each. Group 1: Patients treated with Tablet Mifepristone 25mg once daily for 3 months; Group 2: Patients treated with Inj. Leuprolide acetate depot preparation 3.75mg IM once a month for 3 months. Demographic data, history, clinical examination, details of drug prescription, laboratory investigations and imaging reports were recorded in the study proforma. Various clinical assessment parameters were assessed. Results: After three months of treatment, there was a marked relief with significant decrease in visual analog scale score in both the groups (p <0.001). 21 patients (60%) in group 1 and 25 patients (71%) in group 2 presented with mild anemia at the beginning of the study. After three months of treatment, there was a significant (p <0.001) rise in the hemoglobin and hematocrit values in both the groups. There was an increase in mean hemoglobin level by 2.9gm/dl in mifepristone group and 3gm/dl in leuprolide group. Conclusion: Treatment with either mifepristone or leuprolide acetate in uterine leiomyoma is safe and causes significant but temporary reductions in uterine size and myoma related symptoms.

Keywords

Leuprolide acetate, Mifepristone, Uterine myoma.

History

Received 01 April 2019

Accepted 01 April 2019

DOI

10.21276/ajmr.2019.8.2.PC1

Author Notes

Corresponding Author: Dr. Junaid Naina M, Post Graduate Student, Department of Pharmacology, Sree Narayana Institute of Medical Science, Chalakka, Emakulam.

Open Access

It is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits authors to retain ownership of the copyright for their content, and allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. https://creativecommons.org/licenses/by/4.0/

Copyright

Copyright: © the author(s), 2019.

Cite this Article

Formats

                                                
Actions
Download PDF
Metrics
7
Downloads
7
Views
Journal
Journal Asian Journal of Medical Research
Volume Volume 8
Issue Issue 2
Year 2019

Purchase access plans

Select the plan that best fits your need

Loading plans...

Statistics:

Views: 0
Downloads: 0

Asian Journal of Medical Research (AJMR) is an international, peer-reviewed, quarterly open-access journal publishing advanced research across medical specialties.

Quick Links

For Authors

© 2026 Asian Journal of Medical Research. All Rights Reserved.Designed and Developed By Kryoni